Book an Appointment
Dr. Ankur Nandan Varshney

Dr. Ankur Nandan Varshney

Consultant 

14 years of experience

Medical Oncologists

MBBS, MD, DM

Reg. No.:69367, Delhi Medical Council

Medanta - The Medicity Hospital, Gurgaon

English

Consultation Fee ₹ 1500

Book an Appointment

About Dr. Ankur Nandan Varshney

  • Dr. Ankur Nandan Varshney is an accomplished medical oncologist with an impressive 14 years of experience.
  • He specializes in areas such as cancer immunotherapy, breast cancer, GI malignancies, lung cancer, urogenital cancers, multiple myeloma, lymphoma, leukemia, pediatric solid tumors, stem cell transplantation, and pain and palliative care.
  • His educational qualifications include an MBBS from Banaras Hindu University 2010, an MD in General Medicine from Banaras Hindu University 2014, and a DM in Medical Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi, 2021
  • Dr. Varshney has presented numerous papers at international conferences, showcasing his expertise and dedication to advancing the field of medical oncology.
  • He is committed to delivering exceptional patient care while actively contributing to the progress of medical oncology.

Education

  • MBBS, Banaras Hindu University, 2010
  • MD (General Medicine), Banaras Hindu University, 2014
  • DM (Medical Oncology), All India Institute of Medical Sciences (AIIMS), New Delhi, 2021

Past Experience

  • All India Institute of Medical Sciences (AIIMS), New Delhi 
  • Safdarjung Hospital New Delhi 
  • National Cancer Institute Jhajjar Haryana

Awards

  • Won Deeptanshu Vedanta Gupta Gold Medal
  • Won “Best Poster Prize and Gold Medal” at UP-APICON 2013
  • Selected and attended ESMO Lung preceptorship in November 2020
  • Won ESH scholarship award for the 22nd John Goldman Conference 2020
  • Won a Young Investigator travel grant for the SOHO Conference 2021.
  • Selected for Young Investigator Award for SOHO conference 2022

Paper Published

  • CML-362 Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients of Chronic Myeloid Leukemia–Chronic Phase and Correlate Its In-Vivo Activity With STAT1, STAT5, and AKT 1 Levels
  • 515P Prognostic significance of elevated serum tumor markers (STM) after the first cycle of chemotherapy in patients with intermediate and poor risk non-seminomatous testicular germ cell tumors (NSGCT)
  • Prognostic significance of raised serum tumor markers (STM) after two cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-center in India.
  • Comparison of quality of life (QoL) in survivors of testicular nonseminomatous germ cell tumor (NSGCT) with age-matched controls using EORTC QLQ-C30 questionnaire.
  • CML-268: Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients with CML-CP
  • Poster: CML-268: Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients with CML-CP
  • Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
  • 471PChemotherapy in advanced thymic malignancies
  • Primary Plasma Cell Leukemia: a retrospective series from a tertiary care center in India
  • Preemptive plerixafor-based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation
  • Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
  • Preemptive plerixafor-based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation

Field of Expertise

  • Chemotherapy
  • Endometrial Biopsy
  • Fine Needle Aspiration
  • Hormone Therapy
  • Immunotherapy
  • Microsurgical Tumor Removal
  • Minimally Invasive Cancer Surgery
  • Mohs Surgery
  • Oncological Surgery
  • Ovarian Biopsy
  • Pap Smear
  • Radiation Therapy
  • Acute Lymphocytic Leukemia
  • Adnexal Tumor
  • Adult Hodgkins Lymphoma
  • Astrocytoma
  • Atypical Hyperplasia
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Bone Cancer
  • Brain Stem Glioma
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Carcinoid Syndrome
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Chordomas
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Ductal Carcinoma in Situ (DCIS)
  • Elevated PSA (Prostate-Specific Antigen) Level
  • Eosinophilia
  • Esophageal Cancer
  • Esophagectomy
  • Estrogen Dependent Cancers
  • Extrahepatic Bile Duct Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Fanconi Anemia (FA)
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Gangrene
  • Giant Cell Tumor
  • Gliomas Tumors
  • Head and Neck Cancer
  • Heart Cancer
  • Hemangiopericytoma
  • Hemophilia
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hodgkin Lymphoma
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Malignant Peripheral Nerve Sheath Tumor (MPNST)
  • Mediastinal Teratoma
  • Nasal Cancer
  • Nasopharyngeal Angiofibroma
  • Olfactory Neuroblastoma
  • Ophthalmic Cancer
  • Optic Nerve Glioma
  • Paranasal Tumor
  • Pediatric Spinal Tumor
  • Pigmented Villonodular Synovitis (PVNS)
  • Polycythemia Vera
  • Sacrococcygeal Teratoma (SCT)
  • Tarlov Cysts
View All

Now Request Doctor Appointment in Easy Steps

Best Oncology Doctors in India

View All
View All
Enquiry Now